AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, has unveiled its most advanced ECG system yet — the KardiaMobile® 6L Max — alongside KardiaAlert, a pioneering AI-powered feature. These innovations, available exclusively to KardiaCare subscribers, aim to redefine remote cardiac monitoring by offering wider arrhythmia detection, timely alerts, and access to expert reviews by board-certified cardiologists.

The KardiaMobile 6L Max is designed to support early detection of heart rhythm abnormalities by providing six-lead ECG readings that are analyzed using advanced artificial intelligence. By integrating with KardiaAlert, the device continuously compares each ECG to a baseline and identifies even subtle changes that could indicate a developing heart condition. If an anomaly is detected, the reading is sent for cardiologist review, empowering patients to act before symptoms worsen.

With heart disease continuing to be a silent and gradual threat worldwide, this new solution addresses the growing need for at-home, real-time cardiac monitoring. According to AliveCor, the 6L Max is the only personal ECG system capable of detecting up to 20 arrhythmias with clinician oversight — a capability traditionally reserved for in-clinic devices.

AliveCor emphasizes that this solution not only enhances patient peace of mind but also optimizes healthcare delivery by allowing cardiologists to focus on patients in need of immediate in-person care. The KardiaMobile 6L Max is now available on Kardia.com and will soon be available on Amazon.

MedTech Summary:

• AliveCor’s KardiaMobile 6L Max detects up to 20 arrhythmias using AI and six-lead ECG readings.

• KardiaAlert feature scans ECGs over time and flags concerning changes for cardiologist review.

• Combines remote patient monitoring with expert clinical insight for proactive heart health care.